SCHEMBL20055446

SCHEMBL20055446

Cc1ncc(PC(=O)OCc2ccccc2)[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.44
▸ RAB9A P51151 5/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ POLB P06746 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ STAT1 P42224 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40
▸ MMP2 P08253 2/20 0.39
▸ MMP9 P14780 2/20 0.39
▸ MMP12 P39900 2/20 0.39
▸ MMP1 P03956 1/20 0.39
▸ LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20181861 0.76 MMP2 (0.55) ALDH1A1RAB9ANPC1POLBMAPK1
SCHEMBL20055444 0.71 MAPT (0.40) ALDH1A1RAB9ANPC1POLBMAPT
SCHEMBL4019038 0.70 NPC1 (0.58) RAB9ANPC1POLBSMN1; SMN2
SCHEMBL21768810 0.69 ALDH1A1 (0.62) ALDH1A1RAB9ANPC1MAPK1MAPT
SCHEMBL27604366 0.68 LMNA (0.47) POLBMAPK1MAPTSMN1; SMN2L3MBTL1
SCHEMBL20181862 0.68 KMT2A (0.50) ALDH1A1RAB9ANPC1POLBMAPK1
SCHEMBL25101188 0.67 LMNA (0.68) ALDH1A1POLBMAPK1MAPTSMN1; SMN2
SCHEMBL20181865 0.66 KMT2A (0.51) ALDH1A1RAB9ANPC1POLBMAPK1
SCHEMBL19863279 0.65 ALDH1A1 (0.56) ALDH1A1RAB9ANPC1MAPK1MAPT
SCHEMBL20305861 0.65 TDP1 (0.64) ALDH1A1RAB9ANPC1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3309157-A1 ANTIVIRAL COMPOUNDS Gilead Pharmasset LLC (US) 2018-04-18 — — EP disclosed
Send feedback